Research and Development Protocol Submission and Continuing Review Processes Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas.

Slides:



Advertisements
Similar presentations
Tips to a Successful Monitoring Visit
Advertisements

1 The HIPAA Privacy Rule and Research This presentation will probably involve audience discussion, which will create action items. Use PowerPoint to keep.
RESEARCH COMPLIANCE Agenda 1. No Destruction of local research documents after scanning 2. Training for shipping biological samples/specimens 3. Regulatory.
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
Health Insurance Portability Accountability Act of 1996 HIPAA for Researchers: IRB Related Issues HSC USC IRB.
Common Errors to avoid in IRB- 03 (VA) Applications.
CRC Protocol Documents Protocol Submissions Amendments Publications Study Closure.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
Exempt Research Mary Banks BS, BSN IRB Director CRC IRB and BUMC IRB.
Form I-9 Process An Online Training for Supervisors and Designees Presented by Human Resources Revised November 2009.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
Identification & Distinction of Clinical Trial Participant Charges Bethany Martell Office of Clinical Research Associate Director- Financial Operations.
Data Repositories - Anticipated Policy VHA Handbook Research Accountability Meeting Dr. Joan P. Porter Office of Research Oversight ORO Human Subject.
Documentation of Human Subjects Research in the Patient’s Health Record Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas Veterans.
Instructions for VCU’s Internal Approval Form Form is required to obtain Authorized Official’s signature on proposals and awards OSP – 8/2006.
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
Health Insurance Portability and Accountability Act (HIPAA)
VA Research: IRB and R&D Approval Process From Initial Submission, Through the Informed Consent Process and Continuing Review, To Inactivation Kimberly.
2012 VA IRB Administrators Meeting Stephania H. Griffin, JD, RHIA, CIPP/G VHA Privacy Officer Director, Information Access and Privacy Privacy Officer.
Credentialing for Research Staff Engaged in Human Research Projects at the Atlanta VAMC 1.
Syracuse VAMC HRPP Office Serving Bath, Canandaigua &
Continuing Review VA Requirements Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education (PRIDE)
New Research Service Standard Operating Procedures Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas Veterans Health Care System.
VA MOU’s The Good, the Bad and the Ugly Chris G. Green, CPA Director, Sponsored Programs.
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
1 NJ Dept. of Health Decision Tree for eIRB Submission Revised: 06/18/2015 Is this research defined as: A systematic investigation which includes research.
ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.
IRB Training May 2014 Michele Myrvik Program Specialist Research & Development VA Ext 7645.
Conflict of Interest Policy Implementation October 23, 2014.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
IRB Board Education Session 6 How Consent Regulations are Implemented in INSPIR Mary Banks Director, Office of the IRB June -July 2005.
Deciphering the Continuing Review Form Research Compliance Administration Training Presentation Wednesday, August 15, 2007 Presenter:Heather Kemp, MBA.
STVHCS Research and Development Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas Veterans Health Care System Research & Development.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Office of the Vice Chancellor for Research 1 Update on PHS New Rule on Financial Conflicts of Interest (FCOI) Presentation to Business Managers January.
HIPAA and Research Basics for IRB Tim Atkinson Director, Research and Sponsored Programs Director, Institutional Review Board Research Privacy Officer.
AAHRPP Association for the Accreditation of Human Research Protection Programs Thanks to: Lisa Demanuel, Program Specialist Brain Rehabilitation Research.
Ensuring Human Subject Protection A Guide for Those who Obtain Research Informed Consent Documents 10/15/20151.
H I P A A T R A I N I N G Self Directed Module 7 Research Disclosures For Data Custodians START Click to begin…
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
VA Central IRB Annette Anderson, MS, CIP VA Central IRB Administrator Updated: September 21, 2015.
AUDIT REQUIREMENTS, FINDINGS & BASICS RESEARCH COMPLIANCE.
VHA Handbook What’s new. General Requirements for Informed Consent A Legally Authorized Representative may not always qualify as a ‘personal representative’
1 Role of the Privacy Officer on the IRB Stephania H. Griffin, RHIA, CIPP/G VHA Privacy Officer.
Renewals A HOW-TO. Objectives 1.Why are renewals necessary? 2.What projects require a renewal? 3.How do I find the form? 4.How do I fill out the form?
Human Subjects Research Office of Responsible Research Practices Human Subjects Research Vanessa Hill, MSHS, CCRC Senior Quality Improvement Specialist.
Amendments A HOW-TO. Objectives 1.What is an amendment? 2.What projects are required to submit an amendment? 3.How do I find the form? 4.How do I fill.
Paul Kelly Facility Research Compliance Officer for the Ralph H. Johnson VA Medical Center.
Office for Research Subjects (ORS) & Research Administration (ORA) In-Sync to Help Make your Research Happen Stephanie Gaudreau, Sr.Research Subjects Specialist,
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
INVESTIGATOR RESPONSIBILITIES C. Karen Jeans, MSN COACH Project Analyst.
May 5, 2016 Working With CTO Contracting: How Do I Get My Clinical Trial Contract Negotiated & Why Isn’t It Signed Yet? Jaci Brown, Manager, CTO-Contracting.
Boston Medical Center Provider Onboarding Overview Boston Medical Center Provider Onboarding Overview Bob DeMayo Director, Medical Staff Affairs & Credentialing.
IRB BASICS BETTY WILSON, MS, CIP. CONCEPTS SUBMISSION APPROVAL RECRUITING WORKING WITH PRINCIPAL INVESTIGATOR (PI) /SPONSOR POLICIES DEVIATIONS RECORD.
Session 2 IRB Training  What is the Principal Investigator’s role in Human Subject Research?  What is the role of the Investigator’s staff in Human Subject.
Responsibilities of Sponsor, Investigator and Monitor
The Role and Responsibilities of the Clinical Research Coordinator
Stephanie Oppenheimer, MS SUCCESS Center Erica Ellington, CRA, CHRC
Responsibilities of Sponsor, Investigator and Monitor
Investigator of Record – Definition
Amendments A how-to Prepared by: Christine Melton-Lopez, IRB Associate.
Alyssa Speier, MS, CIP November 13, 2013
Dining with Diabetes IRB Training 2017.
Top Ten eIRB Application Mistakes
Elements of an Organized Regulatory Binder
Basics of Building and Understanding Data Collection Forms
Investigator of Record – Definition
Investigator of Record – Definition
Presentation transcript:

Research and Development Protocol Submission and Continuing Review Processes Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas Veterans Health Care System Research & Development Service

When is R&D Committee Approval Needed? R&D Committee approval is required to conduct any and all VA research What constitutes VA research?

Definition of VA Research Research sponsored by the VA Research conducted using any property or facility of STVHCS Research conducted by or under the direction of any salaried or without compensation (WOC) employee of the STVHCS during and in connection with her/his STVHCS responsibilities Funds for the research activities are managed by the STVHCS or Biomedical Research Foundation of South Texas Research which recruits subjects at the STVHCS or uses the STVHCS's nonpublic information to identify or contact human research subjects for research purposes

R&D Approval – –Must have R&D approval letter prior to any of the following being conducted at the VA Recruitment Obtaining informed consent – –Having an IRB approved VA consent form does NOT constitute R&D approval Enrollment Providing patient follow up – –An IRB approval letter does NOT constitute R&D approval

CPRS can be accessed for information on any Veteran enrolled in a research protocol? YES – –For VA approved research – –Following signed informed consent by the veteran – –As per approved research protocol NO – –For Veterans enrolled in non-VA approved research Must obtain a signed release of information from the subject and receive copies thru Medical Records

Research and Development Protocol Submission Process

Requirements for R&D Submission

What Does It Mean To Have Research Privileges at the STVHCS?

Research Privileges Research credentialing and privileges are required prior to work on any VA protocol Requirements are different for the following groups – –VA Employees Investigators and study personnel – –Fellows, Residents, and Students – –Non-VA investigators or study personnel – –Exempt study staff

VA Research Privileges for VA Employees Copies of training certificates – –Documentation of Human Subjects Training and VA Data Security Training Conflict of Interest Form – –NEW REQUIREMENT – –Required for all investigators and study personnel Scope of practice – –Required for all investigators and study personnel EXCEPT credentialed medical staff providers – –Signed by principal investigator(s) and/or supervising physician

VA Research Privileges for Fellows, Residents, and Students Copies of training certificates – –Documentation of Human Subjects Training and VA Data Security Training Conflict of Interest Form – –NEW REQUIREMENT Scope of practice – –Signed by supervising physician(s) and principal investigator Signed Intellectual Property Agreement (IPA) Copy of appointment memo – –Obtained from the VA Education Office – –Education Office (210) ext 15109

VA Research Privileges for Non-VA Employees – –Without Compensation (WOC) appointment for Research Privileges Submit through the appropriate service Must request Research privileges for correct routing – –Copies of training certificates Documentation of Human Subjects Training and VA Data Security Training – –Conflict of Interest Form NEW REQUIREMENT Required for all investigators and study personnel – –Scope of practice Signed by principal investigator(s) – –Signed Intellectual Property Agreement (IPA) – –Signed Written Release of Information

VA Research Privileges for Contract Credentialed Medical Care Providers – –Without Compensation (WOC) appointment for Research Privileges Submit through the appropriate service Must request Research privileges for correct routing Attach Medical Staff Member Appointment Request signed by appropriate Service Chief – –Form available from Medical Staff Office – –Copies of training certificates Documentation of Human Subjects Training and VA Data Security Training – –Conflict of Interest Form NEW REQUIREMENT – –Signed Intellectual Property Agreement (IPA)

Exempt Personnel Study personnel who are not physically conducting research on VA property, only have access to de-identified data and/or not directly working with research subjects – –Examples: lab personnel, data or administrative personnel Requirements – –Copies of training certificates Documentation of Human Subjects Training and VA Data Security Training – –Memorandum from PI denoting what their role in the study will be – –Conflict of Interest Form

Changes in Personnel Changes to personnel list submitted to IRB – –IRB Form B-2 For personnel engaged in research conducted at the VA – –IRB will verify with the R&D office that all study personnel have submitted the required documentation and been assigned research privileges at the VA prior to approval of the amendment

New Conflict of Interest (COI) Form and Procedures

Conflict of Interest Form No longer protocol specific Required for all investigators and collaborators – –Collaborators = all research personnel New form will be collected as part of – –New personnel application – –New protocol submission if old version of form is on file Must be verified as accurate or updated annually – –Continuing review – –New protocol submission if investigator or personnel have not been engaged in research for greater than one year

New Protocol Submission and COI COI forms no longer required for protocol submission – –Must verify on “Green Sheet” if a COI form is on file for each member of the research team Transition from old form to new form – –Must have form Version 1 dated May 2008 on file

NEW COI Form

Most Commonly Missed Information for R&D Submissions

Requirements for R&D Submission

VA Form Investigator Data Sheet Required for all NEW principal investigators – –Must have one on file for every principal investigator Information entered into VA research tracking database

Requirements for R&D Submission

Research Protocol Safety Survey Required for ALL submissions If all answers are NO – –Documented review by the Research Safety Subcommittee is still required prior to R&D approval – –Assurance of study personnel safety Protocol required blood draws require answering YES to item 1.b.

Requirements for R&D Submission

VA Research Data Security Checklist Required for ALL submissions If the research does NOT involve human subjects OR their identifiable information – –Only PI signature on front page is required for completion

Most Common Discrepancies Noted for R&D Submissions

VA Form Investigational Drug Information Form Must be submitted for all drugs used in research – –Provides information to all healthcare providers regarding potential drug-drug interactions, side effects, antidotes if available, information on blind breaking if applicable Form O in the UTHSCSA IRB application Must be signed by IRB Director AND R&D Chairman prior to approval and initiation of protocol VA Research Pharmacist will verify it has been scanned prior to dispensing of investigational medication

Authorized Prescribers for Investigational Medications All prescribers for investigational medications must be listed on VA form – –Should be consistent with FDA 1572 Prescribers must be credentialed at the VA to write medication orders – –Should be consistent with Scope of Practice if applicable VA form must be amended if – –Prescribing investigators are added to a protocol – –Principal investigator changes Research Pharmacist verifies orders are received by an investigator listed on the

Data Security Checklist Disclosure of PHI to third parties is listed in informed consent/authorization but not on Data Security Checklist – –Verify PHI must be released versus de- identified information

Data Security Checklist Documentation for retention of PHI is inconsistent – –Protocol data management section states subject identification codes (PHI) need to be retained by the investigator for 15 years – –Data security checklist states data will be stored for 5 years as per VA requirements – –Informed consent document states there is no expiration date for how long your PHI will be used All sections should state the same information

Statement of Clinical Impact Form Procedures must be consistent with protocol Collaborating service will not sign off on statement of clinical impact if information provided is incomplete Time to identify items which can not be done by the VA without additional associated costs

Statement of Clinical Impact Form Statement of Clinical Impact Form to Pathology and Laboratory Service stated routine labs only Fibrinogen and albumin are also to be completed locally CRP-HS, Ceruloplasmin, Fetuin-A, IGF-1are to be sent to a central laboratory

Continuing Review Process

New form VA specific information in addition to IRB continuing review form – –Submission of the IRB continuing review form and/or approval letter to the R&D office is NOT required Exempt research – –VA continuing review form required at least annually – –Updated protocol abstract required anually

Continuing Review Form Page 1 First page required for all research protocols If this is a final report – –All data have been collected and analyzed – –Only page 5 of form is completed

Continuing Review Form Page 1 PI must verify project personnel on file in R&D is accurate PI must verify if duties or procedures have changed for any study personnel PI must verify updated conflict of interest forms are on file for all active study personnel PI must verify if data is being collected, stored, or used in a new or different way

Continuing Review Form Human Subjects Research Section Page 2 Updates to VA form (Investigational Drug Information) Verify Research Pharmacy has current protocol, consent form, and Exempt protocols complete page 5

Continuing Review Form Research Safety Section Page 3 Continuing review by the Research Safety Subcommittee is required at least annually PI must verify if any changes to the Research Protocol Safety Survey are required PI must verify all research personnel are familiar with the current Research Protocol Safety Survey Remember blood draws require Research Safety Subcommittee review initially and annually

Continuing Review Form Project Update / Summary Section Page 5 Required for all human EXEMPT projects with each continuing review – –Must be at least annually Required for all human projects if final continuing review is being submitted – –All research projects are completed and all data have been analyzed – –Project will be inactivated in R&D office

Continuing Review Process Protocol approval will expire if – –Continuing review is not completed Must be approved by IRB AND R&D Committee prior to the expiration date – –Training requirements for the PI are not up-to-date at the time of continuing review Co-investigators and other study personnel will be removed from active protocols if training requirements are not up-to-date ALL activities related to the research protocol must immediately cease if approval expires – –Except those activities required to ensure the safety of enrolled subjects Expiration of approval will be corrected upon receipt and satisfactory review and approval of the required documentation

All Training Session Slides Are Now Available On-line

Questions? Kimberly Summers, PharmD Office: (210) ext